Switchblade trait for broad-spectrum disease resistance in tomatoes

Technology
Conceptual
Company

Upstream Biotechnology's SwitchBlade trait enhances disease resistance in tomato plants by rapidly activating immune responses without compromising yield. Suitable for gene editing, it targets diverse pathogens including fungi, bacteria, and viruses.

Overview

Upstream Biotechnology introduces the SwitchBlade trait, a revolutionary approach to enhancing disease resistance in tomato plants. This technology leverages a unique 18-nucleotide sequence that enables rapid translation of immune regulator mRNAs in response to pathogen attacks. This mechanism provides robust resistance against a range of pathogens, including fungi, bacteria, and some viruses. Notably, the SwitchBlade trait is designed to deactivate once the threat is removed, allowing the plant to return to normal growth and avoid yield penalties.

Technical specifications
  • Key Features:
    • Rapid activation of immune responses at the translational level, offering faster and more controlled resistance.
    • Compatible with gene editing techniques, allowing targeted insertion into desired resistance genes.
    • Proven efficacy across multiple crop species, including rice, soybean, tobacco, potato, and tomato.
    • Versatile application potential in specialty crops such as vegetables.
  • Validation Procedures:
    • Construction of vectors for both ectopic expression and targeted insertion of the SwitchBlade sequence.
    • Molecular analysis to confirm successful integration and activity of the trait in transgenic tomato lines.
    • Field trials in rice and soybean demonstrate effectiveness and absence of yield drag.
Technology readiness level

The SwitchBlade trait is currently at Technology Readiness Level 3, indicating that it has been validated in laboratory settings and initial field trials. Future validation steps include further molecular analysis and disease resistance assays in modified tomato lines, aiming to confirm the efficacy and integration of the trait.


About Upstream Biotechnology

Upstream Biotechnology, Inc. is an agtech company based in Durham, North Carolina, focused on enhancing crop resilience and sustainability through advanced plant biotechnology. The company has developed a proprietary gene expression platform, including its SwitchBlade technology, which utilizes RNA switches to monitor environmental stress and activate a plant's natural defense mechanisms on-demand. By creating these sophisticated trait solutions, Upstream aims to provide broad-spectrum disease resistance in major crops, such as soybeans and rice, while eliminating the need for excessive chemical pesticide applications and mitigating yield drag associated with traditional stress responses.

This technology is significant for the agricultural sector as it addresses the growing global demand for food security, climate-smart farming, and sustainability. By enabling crops to protect themselves from diverse pathogens and abiotic stresses, Upstream helps growers maintain reliable, high-quality yields in a changing climate. The company actively engages in strategic partnerships, such as its collaboration with Bene Seeds to develop disease-resistant heirloom tomato varieties, and participates in innovation programs like AgLaunch365 to validate and scale its seed-based solutions for broader commercial application.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.